login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
BAUSCH + LOMB CORP (BLCO.CA) Stock News
TSX:BLCO -
CA0717051076
-
Common Stock
20.02
CAD
-0.18 (-0.89%)
Last: 8/22/2025, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BLCO.CA Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Board Changes
9 days ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb to Participate in Upcoming Investor Conferences
24 days ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Second-Quarter 2025 Results
25 days ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
2 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
2 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
2 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
2 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering
2 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
3 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
3 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
3 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results
3 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
3 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States
4 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
4 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces First-Quarter 2025 Results
4 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall
5 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses
5 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30
5 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States
6 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance
7 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Provides Update on Potential Sale
7 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19
7 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences
7 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union
8 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual “Faces of Glaucoma” Campaign and Fundraising Challenge
8 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
8 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Responds to Rumors of a Potential Sale
8 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities
9 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
10 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Third-Quarter 2024 Results
10 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
11 months ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Second-Quarter 2024 Results
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
a year ago - By: Bausch + Lomb Corporation
- Mentions:
BLCO
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
Please enable JavaScript to continue using this application.